Biomedical Advanced Research
and Development Authority
The Biomedical Advanced Research and Development Authority (BARDA), within the Office of the Assistant Secretary for Preparedness and Response in the U.S. Department of Health and Human Services, provides an integrated, systematic approach to the development and purchase of the necessary vaccines, drugs, therapies, and diagnostic tools for public health medical emergencies.
BARDA manages Project BioShield, which includes the procurement and advanced development of medical countermeasures for chemical, biological, radiological, and nuclear agents, as well as the advanced development and procurement of medical countermeasures for pandemic influenza and other emerging infectious diseases that fall outside the auspices of Project BioShield. In addition, BARDA manages the Public Health Emergency Medical Countermeasures Enterprise (PHEMCE).
BARDA Announces Strategic Plan 2011-2016
The nation has endeavored over the past ten years to become better prepared for the medical consequences of catastrophic events such as bioterrorist events and pandemic influenza...
PHEMCE Strategy 2012
The U.S. Government has a responsibility to protect the health and safety of its citizens. The American people continue to face a host of national health security threats...
Newsroom
-
Now open: Broad Agency Announcements
Now open: Broad Agency Announcements for Advanced Research and Development of Medical Countermeasures for Pandemic Influenza and Chemical, Biological, Radiological and Nuclear Threats...
- September 06, 2012 - 2011 BioShield Annual Report to Congress
- September 06, 2012 - New HHS contracts enhance pandemic preparedness
- August 20, 2012 - NIAID issues funding opportunity for treatments for Gastrointestinal Acute Radiation Syndrome
- August 10, 2012 - Acquisition and Advanced Development of a Colony Stimulating Factor (G- or GM-CSF) for mitigation of neutropenia arising from exposure to ionizing radiation
- June 30, 2012 - Solicitation Posted: Anthrax Antitoxins for the Treatment of Inhalational Anthrax
Medical Countermeasures Enterprise
Centers for Innovation in Advanced Development and Manufacturing
- Webcast Announcement: HHS creates new centers to develop, manufacture medical countermeasures
- HHS Creates New Centers
- Centers for Innovation in Advanced Development and Manufacturing (CIADM) Fact Sheet
- Centers for Innovation in Advanced Development and Manufacturing (CIADM) Map
- CIADM Fact Sheet: Emergent Manufacturing Operations LLC
- CIADM Fact Sheet: Novartis Vaccines and Diagnostics, Inc.
- CIADM Fact Sheet: Texas A & M University System